Xi'an Jiaotong-Liverpool University

Homepage > XJTLU Wisdom Lake Academy of Pharmacy > Yixue Qiao

Profile

Dr Qiao has combined expertise in pharmaceutical sciences ranging from pharmaceutical engineering (Bachelor), medicinal chemistry (Master and PhD), to medicine (PhD and Post-doc). She has broad interest in mitochondrial diseases, targeted drug discovery, nanoliposomes, and hydrogel.

Dr Qiao joined the Academy of Pharmacy at XJTLU as an assistant professor in Jan 2023. She completed her postdoctoral training in the University of Newcastle, Australia. She obtained a Dual Award Doctoral Degree of MD in Pharmacology from Shanghai Jiao Tong University, and PhD in Reproductive Medicine from the University of Newcastle.

Contact her by email (Yixue.Qiao@xjtlu.edu.cn) if you are interested in collaboration with her.

Qualifications
- PhD, Shanghai Jiao Tong University - 2021
- PhD, University of Newcastle - 2021
- MS, China Pharmaceutical University - 2015
- BE, China Pharmaceutical University - 2012
Experience
- Assistant Professor - XJTLU - 2023 to present
- Postdoctoral Research Associate - University of Newcastle - 2021 to 2022
Articles
- Guo B, Shu H, Luo L, Liu X, Ma Y, Zhang J, Liu Z, Zhang Y, Fu L, Song T, Qiao Y, Zhang C. Lactate Conversion by Lactate Dehydrogenase B Is Involved in Beige Adipocyte Differentiation and Thermogenesis in Mice. Nutrients, 2023, 15(22):4846.
- Foteva V, Fisher JJ, Qiao YX, Smith R. Does the Micronutrient Molybdenum Have a Role in Gestational Complications and Placental Health? Nutrients, 2023, 15(15):3348.
- Sultana Z, Qiao YX, Maiti K, Smith R. Involvement of oxidative stress in placental dysfunction, the pathophysiology of fetal death and pregnancy disorders. Reproduction, 2023, 166(2):R25-R38.
- Qiao YX, Maiti K, Sultana Z, Fu L, Smith R. Inhibition of vertebrate aldehyde oxidase as a therapeutic treatment for cancer, obesity, aging and amyotrophic lateral sclerosis. European Journal of Medicinal Chemistry, 2020, 187:111948.
- Qiao YX, Dsouza C, Matthews AA, Jin Y, He W, Bao J, Jiang FQ, Chandna R, Ge RW, Fu L. Discovery of small molecules targeting GRP78 for antiangiogenic and anticancer therapy. European Journal of Medicinal Chemistry, 2020, 193:112228.
- Tavallaie M, Voshtani R, Deng XX, Qiao YX, Jiang FQ, Collman JP, Lei F. Moderation of mitochondrial respiration mitigates metabolic syndrome of aging. Proc. Natl. Acad. Sci. U.S.A., 2020, 201917948.
- Deng XX, Shen J, Zhu H, Xiao J, Sun R, Xie FZ, Lam C, Wang J, Qiao YX, Tavallaie MS, Hu Y, Du Y, Li J, Fu L, Jiang FQ. Surrogating and redirection of pyrazolo[1,5-a]pyrimidin-7(4H)-one core, a novel class of potent and selective DPP-4 inhibitors. Bioorg. Med. Chem., 2018, 26(4):903-912.
- Xie J, Yang FZ, Zhang M, Lam C, Qiao YX, Xiao J, Zhang DD, Ge YX, Fu L, Xie DS. Antiproliferative activity and SARs of caffeic acid esters with mono-substituted phenylethanols moiety. Bioorg. Med. Chem. Lett., 2017, 15, 27(2):131-134.
- Yang FZ, Xie FZ, Zhang Y, Xia Y, Liu W, Jiang FQ, Lam C, Qiao YX, Xie DS, Li J, Fu L. Y-shaped bis-arylethenesulfonic acid esters: Potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors. Bioorg. Med. Chem Lett., 2017, 15, 27(10):2166-2170.
- Mou Y, Jian YL, Chen T, Huang ZJ, Qiao YX, Peng SX, Zhang DY, Ji H, Zhang YH. Synthesis and evaluation of 2-cyano-3, 12-dioxooleana-1, 9(11)-en-28-oate-13β, 28-olide as a potent anti-inflammatory agent for intervention of LPS-induced acute lung injury. Chin. J. Nat. Med., 2017, 15(5):347-354.
- Chen T, Mou Y, Tan JN, Wei LL, Qiao YX, Wei TT, Xiang PJ, Peng SX, Zhang YH, Huang ZJ, Ji H. The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice. Int. Immunopharmacol., 2015, 25(1):55-64.
- Qiao YX, Mou Y, Huang ZJ, Kang FH, Lai YS, Zhang YH. Synthesis and antitumor activities of novel CDDO-Me analogues. Journal of China Pharmaceutical University, 2015, 6:289-293.
Proceedings
- Fu L, Xie DS, Qiao YX, Yu JH, Liu WL. 2017. The synthesis and application of a novel series of D-amino acid oxidase inhibitors. Authorization. ZL.201710125044.0
- Fu L, Zhang Y, Yang FZ, Xie FZ, Deng XX, Qiao YX, Jiang FQ, Xie DS. 2017. Synthesis and application of a novel series of acetylcholinesterase inhibitors. Disclosure. 201710818243.X
Grants
- Research Development Funding (RDF). CIA, 2023-2025, 100,000.
- Development of targeted liposomes to localize abnormal parathyroid glands. CIA, 2022. John Hunter Hospital Charitable Trust Committee/John Hunter Hospital Charitable Trust Grant, Australia, A$10,484.
- Development of targeted liposomes to localize abnormal parathyroid glands. CIA, 2022. University of Newcastle, School of Medicine and Public Health, Pilot Grant, Australia, A$9853.
Professional service activities
- Co-founder of the R.E.D.D. (Research, Education, Design, Destigmatization) Center, an Australian Non-profit Constitution (Charity) for Menstruation and Women’s health.
Teaching activities
- APH204, Medicinal Chemistry
- APH405, Modern Separation Techniques and Applications

电话
+86 (0)51288161514
Email
Yixue.Qiao@xjtlu.edu.cn
地址
SD342(SIP Campus-Science Building)
Suzhou Dushu Lake Science and Education Innovation District
Suzhou Industrial Park
Suzhou
P.R.China
215123

Yixue QiaoPhD

Profile

Qualifications

Experience

Articles

Proceedings

Grants

Professional service activities

Teaching activities